Search Results for "Drug"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Drug. Results 2251 to 2260 of 2663 total matches.
Adacel and Boostrix: Tdap Vaccines for Adolescents and Adults
The Medical Letter on Drugs and Therapeutics • Jan 16, 2006 (Issue 1226)
Letter
®
On Drugs and Therapeutics
IN THIS ISSUE
Volume 48 (Issue 1226)
January 16, 2006 ...
The FDA has licensed Adacel (Aventis Pasteur) and Boostrix (GlaxoSmithKline), two new combination vaccines that include tetanus toxoid, diphtheria toxoid and acellular pertussis antigens (Tdap), for use as a booster in adolescents and adults. In the past, older children and adults were not re-immunized against pertussis because of concerns about reactions to the whole-cell vaccine previously used in younger children. The CDC Advisory Committee on Immunization Practices (ACIP) and the American Academy of Pediatrics (AAP) have recommended that either of the new Tdap vaccines replace routine...
H1N1 Vaccine for Prevention of Pandemic Influenza
The Medical Letter on Drugs and Therapeutics • Oct 05, 2009 (Issue 1322)
The Medical Letter
®
On Drugs and Therapeutics
Published by The Medical Letter, Inc. • 1000 ...
The FDA has licensed 4 new monovalent vaccines for prevention of respiratory illness caused by a new influenza A H1N1 virus that appears to be derived from a swine strain. The 5th vaccine should be licensed soon. All of these vaccines are expected to become available in October. An intranasal formulation is expected in the first week of October.
Mercury in Fish
The Medical Letter on Drugs and Therapeutics • Dec 14, 2009 (Issue 1327)
The Medical Letter
®
On Drugs and Therapeutics
Published by The Medical Letter, Inc. • 1000 ...
Recent news articles about mercury in fish may lead some patients to seek more information from their healthcare providers. For most Americans, seafood is the major source of exposure to mercury. The mercury in seafood is in the form of methylmercury, a potential neurotoxin formed by the organification of elemental mercury by marine microorganisms like plankton, which are then consumed by aquatic animals and concentrated up the food chain.
A New Conjugate Meningococcal Vaccine (Menveo)
The Medical Letter on Drugs and Therapeutics • Jul 26, 2010 (Issue 1343)
The Medical Letter
®
On Drugs and Therapeutics
Published by The Medical Letter, Inc. • 145 ...
The FDA has approved Menveo (Novartis), a new quadrivalent conjugated polysaccharide vaccine, for
protection against disease caused by Neisseria meningitidis in people 11-55 years old.
Colonoscopy Preparations
The Medical Letter on Drugs and Therapeutics • Jan 21, 2013 (Issue 1408)
The Medical Letter®
On Drugs and Therapeutics
Published by The Medical Letter, Inc. • 145 ...
Colonoscopy remains the preferred method of colorectal
cancer screening. Many patients consider
cleansing the bowel in preparation for colonoscopy
the most unpleasant part of the procedure, but inadequate
bowel preparation significantly lowers the diagnostic
yield.
Cannabis and Cannabinoids
The Medical Letter on Drugs and Therapeutics • Nov 18, 2019 (Issue 1585)
) despite optimal
prophylaxis with conventional antiemetic drugs such
as palonosetron (Aloxi, and others ...
Cannabis (marijuana) contains more than 60
pharmacologically active cannabinoids; delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)
are the best known. THC is the main psychoactive
constituent of cannabis. CBD, unlike THC, does not
produce intoxication or euphoria.
Low Osmolality Contrast Agents
The Medical Letter on Drugs and Therapeutics • Sep 22, 1989 (Issue 801)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
The US Food and Drug Administration recently approved the marketing of ioversol (Optiray - Mallinckrodt), a new iodinated, low-osmolality, non-ionic X-ray contrast agent. Low-osmolality contrast agents are much more expensive, but they provide as good diagnostic quality as older, high-osmolality contrast media and are claimed to be both better tolerated and safer (Medical Letter, 29:43, 1987).
Insulin Aspart, A New Rapid-acting Insulin
The Medical Letter on Drugs and Therapeutics • Oct 15, 2001 (Issue 1115)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Insulin aspart (Novolog - Novo Nordisk) is the second rapid-acting insulin analog to be approved by the FDA. The first was insulin lispro (Humalog). Insulin aspart differs from human insulin by substitution of aspartic acid for proline in position 28 on the beta-chain.
COVID-19 Updates
The Medical Letter on Drugs and Therapeutics • Apr 18, 2022 (Issue 1648)
, and dosing recommendations. Available at:
www.medicalletter.org/drugs-for-covid-19.
The Medical Letter ...
The FDA has expanded the Emergency Use Authorizations
(EUAs) for the mRNA COVID-19 vaccines
manufactured by Pfizer-BioNTech (Comirnaty) and
Moderna (Spikevax) to allow for their use as a second
booster dose ≥4 months after a first booster dose in
adults ≥50 years old and in persons aged ≥12 years
(Pfizer) or ≥18 years (Moderna) who have undergone
solid organ transplantation or have a condition that
compromises the immune system to a similar extent.
In Brief: Cholic Acid (Cholbam) for Bile Acid Synthesis Disorders
The Medical Letter on Drugs and Therapeutics • Apr 25, 2016 (Issue 1493)
The Medical Letter®
on Drugs and Therapeutics
Volume 58 (Issue 1493) April 25, 2016
Published ...
The FDA has approved oral cholic acid (Cholbam – Retrophin) for treatment of children and adults with bile acid synthesis disorders caused by single enzyme defects and for adjunctive treatment of peroxisomal disorders such as Zellweger spectrum disorders in patients who have liver disease, steatorrhea, or complications from fat-soluble vitamin malabsorption. Patients with these rare inborn errors of bile acid metabolism cannot synthesize primary bile acids such as cholic acid, resulting in reduced bile flow, decreased absorption of fat and fat-soluble vitamins, and development of liver...
